non-alcoholic fatty liver disease, type 2 diabetes, obesity, resistin


The aim of the research was to study the relationship between plasma concentrations of resistin and indicators of enzyme and pigment metabolism in patients with non-alcoholic fatty liver disease (NAFLD) and its combination with type 2 diabetes mellitus (DM-2).

Materials and methods. On the base of Kharkiv Regional Hospital a total of 90 patients were examined, including patients with NAFLD (n = 20) and its combination with DM-2 with normal body weight (n = 20) and obesity (n = 50), as well as 20 healthy volunteers. A complex of clinical, laboratory and instrumental (including liver biopsy in 9 patients) examinations of patients was performed.

Results. A direct relationship was established between the level of resistin and indicators of enzyme and pigment exchange in groups of patients with combined pathology. A significant increase of resistin plasma level, as well as disorders of the liver function were determined in all groups of patients in comparison with the controls. The most marked changes were revealed in patients with combination of NAFLD, DM-2 and obesity.

Conclusions. The established relationship between the level of resistin and the indicators of the liver functional state suggests that an increase of resistin level may reflect the presence of impaired liver function in patients with NAFLD in combination with DM-2, predicting the progression of NAFLD. In order to detect the disorders of liver function in patients with DM-2, it is recommended to determine the level of resistin in patients with NAFLD, especially when concomitant obesity is present. Patients with resistin level (> 8.06 ± 0.23 ng/ml) should be considered at risk of NAFLD progression.



Drapkina O.M., Korneeva O.N. (2016). Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk. Ration pharmacother cardiol,12(4), 424-429.

Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. (2018). Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol, 24, 3361-73.

Younes R, Bugianesi E. (2019). NASH in lean individuals. Semin Liver Dis, 39, 86-95.

Kocot J, Dziemidok P, Kiełczykowska M, et al. (2017). Adipokine profile in patients with type 2 diabetes depends on degree of obesity. Med Sci Monit, 23, 4995–5004.

Lee SH. (2015). Adipokine profiles and metabolic health. Endocrinol Metab (Seoul), 30, 175–6.

Ouchi N., J.L. Parker, J.J. Lugus, K. Walsh (2011). Adipokines in inflammation and metabolic disease Nat. Rev. Immunol., 11 (2011), 85-97. P, Alonso-Iglesias E. (2015). Resistin: insulin resistance to malignancy. Clin Chim Acta, 438, 46–54.

Picu A, Petcu L, Ştefan S, et al. (2017). Markers of oxidative stress and antioxidant defense in Romanian patients with type 2 diabetes mellitus and obesity. Molecules, 22:E714.

Rajkovic N., Zamaklar M., . Lalic K, Jotic A., Lukic L., Milicic T., Singh S. , Stosi L., Lalic N.M. (2014). Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention Int. J. Environ. Res. Pub. Health, 11, 4049-4065.

Costandi J, Melone M, Zhao A, Rashid S. (2011). Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signaling. Circ Res., 108, 727–742.

Dalamaga M. (2014). Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives. Biomark Med., 8, №1, 107–118.

Huang X, Yang Z. (2016). Resistin’s, obesity and insulin resistance: the continuing disconnect between rodents and humans. J Endocrinol Invest, 39, 607–615.

Wei Liu, Xianghai Zhou, Yufeng Li, Simin Zhang, Xiaoling Cai, Rui Zhang, Siqian Gong, Xueyao Han, Linong Ji (2020). Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus. Medicine (Baltimore), .99(6), e19052. doi: 10.1097/MD.0000000000019052

Luo et al., R. Luo, X. Li, R. Jiang, X. Gao, Z. Lü, W. Hua (2012). Serum concentrations of resistin and adiponectin and their relationship to insulin resistance in subjects with impaired glucose tolerance J. Int. Med. Res., 40, 621-630.

Zaidi and Shirwany, S.I.Z. Zaidi, T.A.K. Shirwany (2015). Relationship of serum resistin with insulin resistance and obesity J. Ayub. Med. Coll. Abbottabad, 27, 552-555.

Bertolani C, Sancho-Bru P, Failli P, Bataller R, Aleffi S, DeFranco R, Mazzinghi B, Romagnani P, Milani S, Ginés P, et al. (2006) Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol, 169, 2042–2053.

Shen, C., Zhao, CY., Wang, W. et al. (2014). The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis. BMC Gastroenterol ,14, 39.

Van Haele M., Roskams T. (2017). Hepatic progenitor cells: an update. Gastroenterol Clin North Am, 46, 409-20.

Copyright for articles published in the journal is regulated by the License Agreement for the use of a scientific article in the journal, which is concluded between the author of the article (Licensor) and Kharkov National Medical University (Licensee, publisher of the journal "Inter Collegas"). The licensor grants to the Licensee a non-exclusive non-exclusive license for the use of the article (a license that does not exclude the use of the article by the Licensor and the issuance of licenses to others for use of this article) on the terms and for the period specified in the contract. The licensor (the author of the article) grants the Licensee the right to reproduce the article (publication in the journal "Inter Collegas", publication, duplication, duplication or other reproduction of the article without limiting the circulation of copies, each copy of the article must contain the name of the Licensor; Of general information, including the publication of the article in full or in part on the Internet on the journal page, the right to use the metadata of the article (titles, full names of authors, annotations, bibliography eskih materials) through the dissemination and communication to the public, processing and systematization, as well as inclusion in various databases and in-formational system).

The licensor grants the licensee the right to transfer, store and process his personal data (full name, scientific degree, academic title, place of work and position, contact information of the authors) with the purpose of including them in the database in accordance with the Law of Ukraine No. 2297 - VI "on protection of personal data" from 01.06.2010.

Personal data and metadata of the article are provided for their storage and processing in various databases and information systems, including them in analytical and statistical reporting, creating sound relationships between the objects of works of science, literature and art with personal data, etc. on unlimited territory. The licensee has the right to transfer the specified data for processing and storage to third parties provided that such a fact is notified with the provision of information about the third party (name and address) to the Licensor.